No results for ‘’
Alpa Laboratories Ltd
NSE: ALPA BSE: 532878
₹68.65
(1.02%)
Wed, 17 Jun 2026, 02:57 am
Market Cap (in Cr)144.46
PE Ratio10.11
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KCompany History
1967
- M/s Alpa Laboratories was formed.
1988
- Incorporation of Alpa Laboratories Private Limited.
1997
- Commenced setting up of manufacturing facility at Pigdamber, Indore.
1998
- Converted into a public limited company with the name of Alpa Laboratories Limited.
1999
- Started commercial production of various formulations.
2001
- Received WHO GMP Certification for its manufacturing facilities.
- Entered into an agreement for Contract manufacturing with Plethico Pharmaceuticals Ltd.
2003
- Certified ISO 9001: 2000.
- The manufacturing facility at Pigdamber was approved by the Director General of Quality Assurance (DGQA), India.
- Started export of its Veterinary products and registered 7 veterinary products in Sudan.
2006
- Started participation in international tenders for export.
- Won a major tender from CMS, Sudan.
- Launched Veterinary Division with a new face and ethical promotion of its Veterinary products in 5 states.
- Launched Ethical division for its human products.
2007
- Alpa Laboratories tied up with Vhermann Pharmaceutical Inc, Philippines for distribution of its products.
2010
- The Company recommended a dividend of 10%.
2014
- Ms. Monali Patel was appointed as the Company Secretary and Compliance Officer.
- Alpa Laboratories sold its Unit-II to Ipca Laboratories Limited on a slump sale basis.
2015
- Alpa Laboratories Ltd formed a wholly owned subsidiary named Norfolk Mercantile Private Ltd.